Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,981 | 44,735 | 80,743 | 73,441 | 76,888 |
| Marketable Securities | 50,598 | 43,644 | N/A | N/A | N/A |
| Receivables | 44,944 | 39,913 | 42,610 | 47,663 | 62,467 |
| Inventories | 39,788 | 39,080 | 38,602 | 37,686 | 42,710 |
| TOTAL | $181,156 | $177,852 | $172,474 | $171,062 | $184,960 |
| Non-Current Assets | |||||
| PPE Net | 624 | 664 | 704 | 770 | 804 |
| Intangibles | 92,359 | 99,030 | 105,701 | 111,332 | 190,269 |
| Other Non-Current Assets | 1,860 | 1,897 | 3,086 | 3,255 | 3,995 |
| TOTAL | $94,843 | $101,591 | $109,491 | $115,357 | $195,068 |
| Total Assets | $275,999 | $279,443 | $281,965 | $286,419 | $380,028 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,153 | 15,271 | 15,650 | 13,439 | 19,004 |
| Accrued Expenses | 73,446 | 73,548 | 73,271 | 76,350 | 81,489 |
| Other current liabilities | 3,505 | 3,365 | 3,523 | 3,654 | 13,796 |
| TOTAL | $90,104 | $92,184 | $92,444 | $93,443 | $114,289 |
| Non-Current Liabilities | |||||
| Long Term Debt | 38,840 | 38,729 | 38,621 | 38,514 | 38,866 |
| Other Non-Current Liabilities | 16,537 | 16,377 | 16,406 | 16,459 | 34,000 |
| TOTAL | $55,377 | $55,106 | $55,027 | $54,973 | $72,866 |
| Total Liabilities | $145,481 | $147,290 | $147,471 | $148,416 | $187,155 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,368 | 6,359 | 6,345 | 6,336 | 6,314 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -662,648 | -659,727 | -656,053 | -651,543 | -594,159 |
| TOTAL | $130,518 | $132,153 | $134,494 | $138,003 | $192,873 |
| Total Liabilities And Equity | $275,999 | $279,443 | $281,965 | $286,419 | $380,028 |